Skip to Content
Morningstar

Boston Scientific Corp BSX

Morningstar Rating
Unlock
Stock XNYS Rating as of
$67.42 −0.54 (0.79%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Boston Scientific Is Poised to Accelerate Its Atrial Fibrillation Ablation Business in 2024

Debbie Wang

Boston Scientific has solidified its footing as one of three major cardiac device makers and significantly improved its innovation and operational chops. Boston remains a tough competitor—even a prolonged period of operational and management upheaval from 2006 to 2014 wasn't enough to permanently impair the underlying business and Boston's ability to develop and commercialize new technology platforms. Under CEO Michael Mahoney, the firm has focused on introducing meaningful innovation and leveraging its historically formidable sales and marketing resources.

Read Full Report

Price vs Fair Value

View History
BSX is trading at a 11% premium.
Price
$67.96
Fair Value
$57.00
Uncertainty
Medium
1-Star Price
$75.67
5-Star Price
$89.40
Economic Moat
Mjlmc
Capital Allocation
Xjmhgdkl

Bulls Say, Bears Say

Bulls

Boston remains one of the top players when it comes to intellectual property in the medical technology arena, which bodes well for its ability to innovate enough to keep up with rivals.

Bears

Boston's coronary stent business is less moaty than its cardiac rhythm management segment.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BSX is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$67.96
Day Range
$67.22–68.20
52-Week Range
$48.35–69.21
Bid/Ask
$66.87 / $69.50
Market Cap
$99.10 Bil
Volume/Avg
5.9 Mil / 6.1 Mil

Key Statistics

Price/Earnings (Normalized)
33.23
Price/Sales
7.00
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Growth
Total Number of Employees
48,000
Website
https://www.bostonscientific.com

Competitors

Valuation

View More
Metric
BSX
MDT
EW
Price/Earnings (Normalized)
 33.2314.6435.88
Price/Book Value
 5.182.038.14
Price/Sales
 7.003.269.14
Price/Cash Flow
 30.4514.4238.59
Price/Earnings
BSX
MDT
EW

Financial Strength

Metric
BSX
MDT
EW
Quick Ratio
 0.631.462.08
Current Ratio
 1.322.303.38
Interest Coverage
 8.418.8687.98
Quick Ratio
BSX
MDT
EW

Profitability

Metric
BSX
MDT
EW
Return on Assets (Normalized)
 8.92%7.75%17.13%
Return on Equity (Normalized)
 16.33%13.75%24.32%
Return on Invested Capital (Normalized)
 11.43%9.87%21.12%
Return on Assets
BSX
MDT
EW
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Devices Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesKkhvpqpsKqptwl$182.7 Bil
SYK
Stryker CorpFggvgqxmrpNtpp$124.6 Bil
MDT
Medtronic PLCWkmdcvkJngqb$105.0 Bil
EW
Edwards Lifesciences CorpXjkwkhbbkvHxcpcrf$52.0 Bil
DXCM
DexCom IncShcbpyfwYgdy$51.8 Bil
ZBH
Zimmer Biomet Holdings IncKyxhdlcnptYhgch$24.9 Bil
ALGN
Align Technology IncCrjrnwxcTddnqc$22.6 Bil
PHG
Koninklijke Philips NV ADRShpdzbsPkmntmk$18.2 Bil
PODD
Insulet CorpZgzmyyyrMkjzp$11.6 Bil

Sponsor Center